Federal Circuit Says Cordis Likely To Prevail In Patent Case Vs. Boston Scientific

Law360, New York (June 1, 2004, 12:00 AM EDT) -- The Court of Appeals for the Federal Circuit in Washington, D.C. has confirmed that Cordis Corp. is likely to prevail at trial on the merits of claims that its core patent on balloon expandable stents is valid and infringed by Boston Scientific's Taxus Stent.

However, the court affirmed a lower court ruling denying Cordis Corporation a preliminary injunction barring sales of the Boston Scientific’s Taxus stent, citing a lack of irreparable harm from denial of the injunction.

"We are disappointed the Court of Appeals denied the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.